Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Bloomberg
Tuesday, March 19, 2013 - 11:17am
tags:
Titan Pharmaceuticals, FDA, Probuphine, addiction
Zalicus presents data on state-dependent ion channel screening
Yahoo/Fly on the Wall
Tuesday, March 19, 2013 - 11:16am
tags:
Zalicus, ion channel screening, calcium channel blockers
DB Analyst Gets It: Sarepta Is a Winner Even Without Accelerated Approval
TheStreet.com
Tuesday, March 19, 2013 - 11:14am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha
Tuesday, March 19, 2013 - 11:13am
tags:
Progenics, Relistor, Salix, opioid-induced bowel dysfunction
This Protein Could Change Biotech Forever
Forbes
Tuesday, March 19, 2013 - 11:09am
tags:
biotech, Cas9, DNA
Sangamo Biosciences Hits Multi-Year Highs
Seeking Alpha
Tuesday, March 19, 2013 - 11:08am
tags:
Sangamo BioSciences
Will Vivus Publish Qsymia Prescription Data?
Seeking Alpha
Tuesday, March 19, 2013 - 11:07am
tags:
Qsymia, prescription data, Vivus
NPS Buys Back Rights to Gattex From Takeda to Spur Sales
Bloomberg
Tuesday, March 19, 2013 - 11:06am
tags:
NPS Pharmaceuticals, Takeda, Gattex, short bowel syndrome
Fidelity manager says healthcare law, cuts will hit biotech
Reuters
Tuesday, March 19, 2013 - 11:05am
tags:
biotech, healthcare reform
Arena Faces Europe's Obesity Opportunity
Motley Fool
Tuesday, March 19, 2013 - 11:04am
tags:
obesity, Arena Pharmaceuticals, Europe, Vivus, Belviq, Qsymia
Affymax may file for bankruptcy; cuts 75 percent of workforce
Yahoo/Reuters
Tuesday, March 19, 2013 - 11:03am
tags:
Affymax, bankruptcy, layoffs
Novo Nordisk obesity drug results underwhelm investors
Reuters
Tuesday, March 19, 2013 - 11:02am
tags:
obesity, Novo Nordisk, liraglutide
AbbVie CEO 2012 Compensation Valued at $7.9 Million, Up More Than 40%
NASDAQ.com
Tuesday, March 19, 2013 - 10:57am
tags:
Richard Gonzalez, executive pay, AbbVie
Taxpayer Funds, A Pfizer Drug And Big Profits
Pharmalot
Tuesday, March 19, 2013 - 10:56am
tags:
Pfizer, JAK3 inhibitors, Xeljanz, rheumatoid arthritis
NovaBay: Topline Data From 2 Phase IIb Trials Presents Asymmetric Investment Opportunity
Seeking Alpha
Tuesday, March 19, 2013 - 10:54am
tags:
NovaBay Pharmaceuticals, auriclosene, Galderma
Novo Nordisk hit by insulin drug doubts, downgrade
Marketwatch
Tuesday, March 19, 2013 - 10:53am
tags:
insulin, Novo Nordisk, Tresiba
Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer
Yahoo
Tuesday, March 19, 2013 - 10:52am
tags:
Apricus Biosciences
Cardiome Posts 4Q Profit
Yahoo/Zacks
Tuesday, March 19, 2013 - 10:51am
tags:
earnings, Cardiome
3 Big Concerns for the Pharmaceutical Industry
Motley Fool
Tuesday, March 19, 2013 - 10:46am
tags:
generics, drug pricing, Bristol-Myers Squibb, Eli Lilly, GSK, Questcor, KV Pharmaceutical, Sinovac Biotech, Dendreon
Cordis acquires Flexible Stenting Solutions, terms not disclosed
Yahoo/Fly on the Wall
Tuesday, March 19, 2013 - 10:44am
tags:
Cordis, M&A, Flexible Stenting Solutions

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.